Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Cameron C. Trenor III currently holds 233,333 shares of AN2 Therapeutics, Inc. (ANTX), valued at approximately $0. This represents their equity stake as Chief Medical Officer.
Based on SEC Form 4 filings, Cameron C. Trenor III has been a net neutral trader of ANTX stock. They have purchased $0 and sold $0 worth of shares.
Cameron C. Trenor III's most recent insider trade was on Sep 15, 2026, when they sold 233,333 shares at $0.00 per share.
Cameron C. Trenor III serves as Chief Medical Officer at AN2 Therapeutics, Inc. (ANTX). They have executed 2 insider transactions totaling $0 over their tenure at the company.
Cameron C. Trenor III holds the position of Chief Medical Officer at AN2 Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Cameron C. Trenor III has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Cameron C. Trenor III was on Sep 15, 2026, when they purchased $0 worth of ANTX shares. This transaction involved 233,333 shares at N/A per share.
Cameron C. Trenor III currently owns 233,333 shares of AN2 Therapeutics, Inc. (ANTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Cameron C. Trenor III's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Cameron C. Trenor III has 2 Form 4 filings on record as an insider at AN2 Therapeutics, Inc..
Set alerts for Cameron C. Trenor III and 40,000+ other insiders.